# 119-s-3188: Biomanufacturing Excellence Act of 2025

119-s-3188, Biomanufacturing Excellence Act of 2025, is a 119th Congress bill sponsored by Sen. Coons, Christopher A. [D-DE] (D-DE); status introduced; PRIA reads it as touching household money (as of 2026-09-10).

- Canonical: https://policyrisk.com/legislation/119-s-3188
- As of: 2026-09-10
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-3188
- Congress: 119
- Title: Biomanufacturing Excellence Act of 2025
- Status: introduced
- Introduced: 2025-11-18
- Sponsor: Sen. Coons, Christopher A. [D-DE] (D-DE)
- Cosponsors: 5
- Policy area: Science, Technology, Communications
- Touches household money: yes
- Last recorded action: 2026-09-10

## Summary

**National Biopharmaceutical Center of Excellence** would be created inside the National Institute of Standards and Technology to accelerate U.S. biopharmaceutical manufacturing and cut reliance on foreign supply chains. It would promote manufacturing innovation, share best practices, enable public-private collaboration, and support worker training to move lab discoveries into commercial production. - U.S. manufacturers and biotech firms: Would gain access to flexible, affordable development infrastructure to prove scale-up and improve chances of commercializing new medicines. - Workers and training programs: Would receive support for hands-on training to operate advanced biotechnology tools and build sector talent. - Public health, agriculture, and defense: Would benefit from stronger domestic manufacturing capacity that the bill ties to better treatment options, food resilience, and military capabilities.

## Cosponsors (5)

- Sen. Budd, Ted [R-NC] (R-NC), 2025-11-18T00:00:00.000Z
- Sen. Padilla, Alex [D-CA] (D-CA), 2026-03-11T00:00:00.000Z
- Sen. Young, Todd [R-IN] (R-IN), 2026-03-11T00:00:00.000Z
- Sen. Tillis, Thomas [R-NC] (R-NC), 2026-05-14T00:00:00.000Z
- Sen. Blunt Rochester, Lisa [D-DE] (D-DE), 2026-05-19T00:00:00.000Z

## Provisions PRIA read

- National Biopharmaceutical Center and Funding: benefit, high. This bill would direct NIST to fund and pick one non‑federal group to run a National Biopharmaceutical Manufacturing Center of Excellence. It would authorize $120,000,000 for fiscal year 2026 to support the Center. The Director would solicit applications and must award a grant or agreement within 1…

## Related bills

- 119-s-5066: Health Equity and Accountability Act of 2026
- 119-s-1241: Sanctioning Russia Act of 2025
- 119-s-199: A bill to amend the Internal Revenue Code of 1986 to provide special rules for the taxation of certain residents of Taiwan with income from sources within the…
- 119-s-1289: 25th Anniversary of 9/11 Commemorative Coin Act
- 119-s-1547: America the Beautiful Act
- 119-s-522: Credit Union Board Modernization Act

## Sources
- [119-s-3188 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/3188)

## Related
- [119-s-5066: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-s-5066)
- [119-s-1241: Sanctioning Russia Act of 2025](https://policyrisk.com/legislation/119-s-1241)
- [119-s-199: A bill to amend the Internal Revenue Code of 1986 to provide special rules for…](https://policyrisk.com/legislation/119-s-199)
- [119-s-1289: 25th Anniversary of 9/11 Commemorative Coin Act](https://policyrisk.com/legislation/119-s-1289)
- [119-s-1547: America the Beautiful Act](https://policyrisk.com/legislation/119-s-1547)
- [119-s-522: Credit Union Board Modernization Act](https://policyrisk.com/legislation/119-s-522)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-3188 (as of 2026-09-10).